Unfavorable prognosis of CRTC1‐MAML2 positive mucoepidermoid tumors with CDKN2A deletions
暂无分享,去创建一个
P. Meltzer | F. Kaye | S. Anzick | Wei-Dong Chen | D. Bell | Yoonsoo Park | A. El-Naggar
[1] J. Lennerz,et al. Mucoepidermoid Carcinoma of the Cervix: Another Tumor With the t(11;19)-associated CRTC1-MAML2 Gene Fusion , 2009, The American journal of surgical pathology.
[2] A. Nicholson,et al. Mammalian mastermind like 2 11q21 gene rearrangement in bronchopulmonary mucoepidermoid carcinoma. , 2009, Human pathology.
[3] D. Ivan,et al. Cutaneous Hidradenocarcinoma: A Clinicopathological, Immunohistochemical, and Molecular Biologic Study of 14 Cases, Including Her2/neu Gene Expression/Amplification, TP53 Gene Mutation Analysis, and t(11;19) Translocation , 2009, The American Journal of dermatopathology.
[4] G. Rossi,et al. Mucoepidermoid carcinoma of the lung, response to EGFR inhibitors, EGFR and K-RAS mutations, and differential diagnosis. , 2009, Lung cancer.
[5] S. Thibodeau,et al. Salivary gland-type lung carcinomas: an EGFR immunohistochemical, molecular genetic, and mutational analysis study , 2008, Modern Pathology.
[6] Y. Bang,et al. Mucoepidermoid carcinoma of lung: potential target of EGFR-directed treatment. , 2008, Lung cancer.
[7] H. Kosmehl,et al. Detection of drug-sensitizing EGFR exon 19 deletion mutations in salivary gland carcinoma , 2008, British Journal of Cancer.
[8] Steven Piantadosi,et al. DNA methylation markers and early recurrence in stage I lung cancer. , 2008, The New England journal of medicine.
[9] Jörn Bullerdiek,et al. A new type of MAML2 fusion in mucoepidermoid carcinoma , 2008, Genes, chromosomes & cancer.
[10] S. Kannan,et al. Differential Roles of p16INK4A and p14ARF Genes in Prognosis of Oral Carcinoma , 2008, Cancer Epidemiology Biomarkers & Prevention.
[11] T. Löning,et al. A closer look at Warthin tumors and the t(11;19). , 2008, Cancer genetics and cytogenetics.
[12] T. Vaněček,et al. Skin-type hidradenoma of the breast parenchyma with t(11;19) translocation: hidradenoma of the breast. , 2007, The American Journal of dermatopathology.
[13] F. Kaye,et al. CRTC1/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors: Implications for histogenesis and biologic behavior , 2007, Genes, chromosomes & cancer.
[14] G. Petruzzelli,et al. Contemporary management of tumors of the salivary glands , 2007, Current oncology reports.
[15] F. Wei,et al. Alterations of p16INK4a tumour suppressor gene in mucoepidermoid carcinoma of the salivary glands. , 2007, International journal of oral and maxillofacial surgery.
[16] M. Luna. Salivary Mucoepidermoid Carcinoma: Revisited , 2006, Advances in anatomic pathology.
[17] F. Kaye,et al. Sustained expression of Mect1-Maml2 is essential for tumor cell growth in salivary gland cancers carrying the t(11;19) translocation , 2006, Oncogene.
[18] Shigeo Nakamura,et al. MECT1-MAML2 Fusion Transcript Defines a Favorable Subset of Mucoepidermoid Carcinoma , 2006, Clinical Cancer Research.
[19] A. Russo,et al. TP53 and p16INK4A, but not H‐KI‐Ras, are involved in tumorigenesis and progression of pleomorphic adenomas , 2006, Journal of cellular physiology.
[20] L. Szekely,et al. Molecular classification of mucoepidermoid carcinomas—Prognostic significance of the MECT1–MAML2 fusion oncogene , 2006, Genes, chromosomes & cancer.
[21] A. El-Naggar. Clear Cell Hidradenoma of the Skin—A Third Tumor Type With a t(11;19)-Associated TORC1-MAML2 Gene Fusion: Genes Chromosomes Cancer. 2005;43:202–205 , 2006, Advances in anatomic pathology.
[22] S. Baylin,et al. Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? , 2006, Nature Reviews Cancer.
[23] L. Mao,et al. Promoter methylation of p16INK4a, RASSF1A, and DAPK is frequent in salivary adenoid cystic carcinoma , 2005, Cancer.
[24] F. Kaye,et al. Mect1-Maml2 fusion oncogene linked to the aberrant activation of cyclic AMP/CREB regulated genes. , 2005, Cancer research.
[25] L. Myeroff,et al. Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. , 2005, Journal of the National Cancer Institute.
[26] J. J. van den Oord,et al. Clear cell hidradenoma of the skin—a third tumor type with a t(11;19)‐associated TORC1–MAML2 gene fusion , 2005, Genes, chromosomes & cancer.
[27] G. Tonon,et al. A study of MECT1-MAML2 in mucoepidermoid carcinoma and Warthin's tumor of salivary glands. , 2004, The Journal of molecular diagnostics : JMD.
[28] U. Lendahl,et al. Altered Notch signaling resulting from expression of a WAMTP1-MAML2 gene fusion in mucoepidermoid carcinomas and benign Warthin's tumors. , 2004, Experimental cell research.
[29] G. Tonon,et al. t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway , 2003, Nature Genetics.
[30] G. Tonon,et al. t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway , 2003, Nature Genetics.
[31] F. Kaye,et al. RB and cyclin dependent kinase pathways: defining a distinction between RB and p16 loss in lung cancer , 2002, Oncogene.
[32] M. Urken,et al. Mucoepidermoid Carcinoma: A Clinicopathologic Study of 80 Patients With Special Reference to Histological Grading , 2001, The American journal of surgical pathology.
[33] D. Sidransky,et al. p16(MTS-1/CDKN2/INK4a) in cancer progression. , 2001, Experimental cell research.
[34] P. Auclair,et al. Mucoepidermoid carcinoma of the major salivary glands: clinical and histopathologic analysis of 234 cases with evaluation of grading criteria , 2000 .
[35] C. Moskaluk,et al. Analysis of chromosome 9p21 deletion and p16 gene mutation in salivary gland carcinomas. , 1999, Human pathology.
[36] Y. Fujioka,et al. Deletion of the p16 Gene and Microsatellite Instability in Carcinoma Arising in Pleomorphic Adenoma of the Parotid Gland , 1998, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[37] G. Ellis,et al. Mucoepidermoid carcinoma of the major salivary glands , 1998, Cancer.
[38] J. Herman,et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. , 1995, Cancer research.
[39] F. Kaye,et al. CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16INK4 protein induction by 5-aza 2'deoxycytidine. , 1995, Oncogene.
[40] J. Batsakis,et al. Histocytologic grading of mucoepidermoid carcinoma of major salivary glands in prognosis and survival: A clinicopathologic and flow cytometric investigation , 1995, Head & neck.
[41] I. Fonseca,et al. Mucoepidermoid carcinoma of the salivary glands: A reappraisal of the influence of tumor differentiation on prognosis , 1991, Journal of surgical oncology.
[42] J. Zeitlhofer,et al. Mucoepidermoid Carcinoma of the Cervix , 1982 .